featured
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials
J. Clin. Oncol 2022 Oct 28;[EPub Ahead of Print], C Gallois, Q Shi, JP Meyers, T Iveson, SR Alberts, A de Gramont, AF Sobrero, DG Haller, E Oki, AF Shields, RM Goldberg, R Kerr, S Lonardi, G Yothers, C Kelly, I Boukovinas, R Labianca, FA Sinicrope, I Souglakos, T Yoshino, JA Meyerhardt, T André, D Papamichael, J TaiebFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.